Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depression-Reference-Cited by-同舟云学术

Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depression

Published:2020-12 Issue: Volume:591 Page:120007
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Bhattaccharjee Sonalika A.,Murnane Kevin S.,Banga Ajay K.^ORCID

Funder

Georgia Research Alliance

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference86 articles.

1. Aan Het Rot, M., Collins, K.A., Murrough, J.W., Perez, A.M., Reich, D.L., Charney, D.S., Mathew, S.J., 2010. Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression, Biol. Psychiatry. 67, 139–145. https://doi.org/10.1016/j.biopsych.2009.08.038.

2. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum;Alkilani;Pharmaceutics.,2015

3. Reply To: Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression;Altinay;Biol. Psychiatry.,2013

4. Microporation applications for enhancing drug delivery;Banga;Expert Opin. Drug Deliv.,2009

5. Transdermal and intradermal delivery of therapeutic agents: application of physical technologies;Banga,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A shea butter-based ketamine ointment: The antidepressant effects of transdermal ketamine in rats;Behavioural Brain Research;2023-08

2. Current and future directions of drug delivery for the treatment of mental illnesses;Advanced Drug Delivery Reviews;2023-06

3. Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain;Journal of Cannabis Research;2023-03-30

4. Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs;Pharmaceutics;2023-03-20

5. Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy;Pharmaceutics;2022-12-16